Waverton Investment Management Ltd acquired a new position in shares of GE HealthCare Technologies Inc. (NASDAQ:GEHC - Free Report) in the 4th quarter, according to its most recent filing with the Securities & Exchange Commission. The fund acquired 626,507 shares of the company's stock, valued at approximately $48,977,000. Waverton Investment Management Ltd owned 0.14% of GE HealthCare Technologies at the end of the most recent quarter.
Several other institutional investors and hedge funds have also made changes to their positions in GEHC. Mesirow Financial Investment Management Inc. lifted its position in GE HealthCare Technologies by 39.6% during the third quarter. Mesirow Financial Investment Management Inc. now owns 4,084 shares of the company's stock valued at $383,000 after purchasing an additional 1,159 shares during the period. Cathy Pareto & Associates Inc. acquired a new position in GE HealthCare Technologies during the fourth quarter valued at $670,000. LMR Partners LLP acquired a new position in GE HealthCare Technologies during the third quarter valued at $7,387,000. Principal Financial Group Inc. lifted its position in GE HealthCare Technologies by 1.9% during the third quarter. Principal Financial Group Inc. now owns 1,009,910 shares of the company's stock valued at $94,780,000 after purchasing an additional 19,010 shares during the period. Finally, B. Metzler seel. Sohn & Co. Holding AG acquired a new position in GE HealthCare Technologies during the third quarter valued at $1,396,000. 82.06% of the stock is currently owned by institutional investors and hedge funds.
Analysts Set New Price Targets
A number of research analysts have weighed in on GEHC shares. Citigroup upped their price objective on shares of GE HealthCare Technologies from $103.00 to $110.00 and gave the stock a "buy" rating in a research report on Thursday, February 13th. Jefferies Financial Group upgraded shares of GE HealthCare Technologies from a "hold" rating to a "buy" rating and upped their price objective for the stock from $95.00 to $103.00 in a research report on Wednesday, January 8th. Finally, Wells Fargo & Company upped their price objective on shares of GE HealthCare Technologies from $96.00 to $103.00 and gave the stock an "overweight" rating in a research report on Friday, February 14th. One investment analyst has rated the stock with a sell rating, three have assigned a hold rating, eight have given a buy rating and one has issued a strong buy rating to the company. According to MarketBeat, the stock has an average rating of "Moderate Buy" and a consensus target price of $97.67.
Get Our Latest Research Report on GE HealthCare Technologies
GE HealthCare Technologies Stock Performance
GE HealthCare Technologies stock traded down $1.31 during midday trading on Thursday, hitting $89.40. 3,926,125 shares of the company's stock were exchanged, compared to its average volume of 2,852,535. GE HealthCare Technologies Inc. has a 12-month low of $74.51 and a 12-month high of $94.80. The company has a debt-to-equity ratio of 0.88, a quick ratio of 0.83 and a current ratio of 1.04. The stock has a market cap of $40.88 billion, a price-to-earnings ratio of 20.65, a price-to-earnings-growth ratio of 3.19 and a beta of 1.15. The firm's 50 day simple moving average is $85.76 and its 200 day simple moving average is $86.05.
GE HealthCare Technologies (NASDAQ:GEHC - Get Free Report) last issued its quarterly earnings data on Thursday, February 13th. The company reported $1.45 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.26 by $0.19. GE HealthCare Technologies had a net margin of 10.13% and a return on equity of 25.74%. The company had revenue of $5.32 billion for the quarter, compared to the consensus estimate of $5.33 billion. Equities research analysts predict that GE HealthCare Technologies Inc. will post 4.68 EPS for the current year.
GE HealthCare Technologies Company Profile
(
Free Report)
GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.
Read More
Before you consider GE HealthCare Technologies, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and GE HealthCare Technologies wasn't on the list.
While GE HealthCare Technologies currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Options trading isn’t just for the Wall Street elite; it’s an accessible strategy for anyone armed with the proper knowledge. Think of options as a strategic toolkit, with each tool designed for a specific financial task. Get this report to learn how options trading can help you use the market’s volatility to your advantage.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
